Tobira Therapeutics Inc.

(TBRA) Trade

By |

Profile

Regado Biosciences Inc was incorporated in Delaware under the name Quartet Biosciences, Inc. in December 2001 and changed its name to Regado Biosciences, Inc. in March 2003. It is a biopharmaceutical company. The Company is engaged in the discovery and development of antithrombotic drug systems for acute and sub-acute cardiovascular indications. The Company's product candidates consists of a two-component system: an aptamer and its specific active control agent. The aptamer is administered first and achieves its therapeutic effect within minutes. When the therapeutic effect of the aptamer is no longer needed, the control agent is administered to rapidly and precisely reduce or eliminate it. The level of reduction is determined by the amount of control agent given compared to the aptamer dose. The Company's product candidate, REG1, consists of pegnivacogin, a highly potent and selective anticoagulant, and anivamersen, its specific active control agent. The Company is developing REG1 as an anticoagulant for use in patients with cardiovascular conditions undergoing percutaneous coronary intervention, or PCI, a hospital-based procedure used to mechanically open or widen obstructed coronary arteries.

Contact Information

Website: www.tobiratherapeutics.com
Main Phone: +1 650 741-6625
Address: 701 Gateway Boulevard
Address 2: Suite 300
State: CA
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NSC
CEO: Laurent Fischer
Employees: 20
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 42.33 52 Wk Low 3.76
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 18,821,231.00 EPS (TTM) -2.61 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Jesse I. Treu 1,000
Anton Gopka 1,000
Raphael Wisniewski 1,000
P. Sherrill Neff 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 42 42 42 42
Low Target Price Estimate 11 11 11 11
Mean Target Price Estimate 24.75 24.75 24.75 24.75
Standard Deviation 14.38 14.38 14.38 14.38
Date of Most Recent Estimate 10/20/16 10/20/16 10/20/16 10/20/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 4 4
Moderate Buy 0 0 0 0
Hold 1 1 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.5 1.5 1 1